Philippe Riou
Altrincham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: January 04, 2026
The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity.
Journal: Journal of cell science
Published: August 09, 2018
Rnd3-induced cell rounding requires interaction with Plexin-B2.
Journal: Journal of cell science
Published: May 10, 2016
RhoC and ROCKs regulate cancer cell interactions with endothelial cells.
Journal: Molecular oncology
Published: August 01, 2014
Functional implications of assigned, assumed and assembled PKC structures.
Journal: Biochemical Society transactions
Published: January 24, 2014
Atypical protein kinase Cι as a human oncogene and therapeutic target.
Journal: Biochemical pharmacology
Published: October 18, 2013
Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids.
Journal: Carcinogenesis
Published: September 28, 2013
A cancer-associated mutation in atypical protein kinase Cι occurs in a substrate-specific recruitment motif.
Journal: Science signaling
Published: September 19, 2013
An antagonistic interaction between PlexinB2 and Rnd3 controls RhoA activity and cortical neuron migration.
Journal: Nature communications
Published: August 22, 2013
Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes.
Journal: The Biochemical journal
Published: February 20, 2013
Cdc42 promotes transendothelial migration of cancer cells through β1 integrin.
Journal: The Journal of cell biology
Published: November 14, 2012
Last Updated: 09/26/2026